NLM Logo

axicabtagene ciloleucel MeSH Supplementary Concept Data 2024


MeSH Supplementary
axicabtagene ciloleucel
Unique ID
C000629083
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629083
Entry Term(s)
KTE-C19
Yescarta
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
U2I8T43Y7R
Heading Mapped to
*Biological Products
Frequency
160
Note
CD19 CAR T cell therapy for treatment of relapsed refractory diffuse large B cell lymphoma (DLBCL), high grade lymphoma, and primary mediastinal B cell lymphoma (PMBCL)
Source
Med Lett Drugs Ther. 2018 Jul 16;60(1551):e122-e123.
Date of Entry
2018/11/28
Revision Date
2021/10/03
axicabtagene ciloleucel Preferred
KTE-C19 Narrower
Yescarta Narrower
page delivered in 0.004s